| __timestamp | Supernus Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 2395000 |
| Thursday, January 1, 2015 | 29135000 | 9057000 |
| Friday, January 1, 2016 | 42791000 | 40818000 |
| Sunday, January 1, 2017 | 49577000 | 79309000 |
| Monday, January 1, 2018 | 89209000 | 134428000 |
| Tuesday, January 1, 2019 | 69099000 | 175431000 |
| Wednesday, January 1, 2020 | 75961000 | 130944000 |
| Friday, January 1, 2021 | 90467000 | 121875000 |
| Saturday, January 1, 2022 | 74552000 | 115856000 |
| Sunday, January 1, 2023 | 91593000 | 130009000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the key to success. Supernus Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Wave Life Sciences consistently outpaced Supernus in R&D spending, with an average annual investment of approximately 94 million dollars, compared to Supernus's 63 million dollars. Notably, in 2019, Wave Life Sciences spent nearly 175 million dollars, marking a peak in their commitment to innovation. Meanwhile, Supernus's highest expenditure was around 92 million dollars in 2023. This trend highlights Wave Life Sciences' aggressive strategy to lead in biotech advancements. As these companies continue to innovate, their R&D investments will likely shape the future of medical breakthroughs.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.